(NG89) YYour responsibilityour responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, ...
We found that there was a significant mismatch between the decision problem and UK clinical practice, and the evidence from the clinical trials in terms of line of therapy, dosing and effect of concomitant therapy. The pop- ulation addressed in the company's decision problem was much narrower,...
0.08 0.418 ± 0.06*** 0.450 ± 0.07*** ––– 1.30 ± 0.12 0.30 ± 0.06 0.668 ± 0.16 0.692 ± 0.08 Linear regressions were performed with dependent variables being the HRQoL test values at the different time points and independent variables including the demo- graphic and clinical variables...
New NICE guideline on chronic fatigue syndrome: More ideology than science? Lancet 2022, 399, 611–613. [Google Scholar] [CrossRef] NICE. Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management, Clinical Guideline, CG53. 22 August 2007. Available online: ...